FDA recently announced the approval of Probuphine, an implantable form of buprenorphine, for treating opioid dependence. National Public Radio sought the views of Dr. Cidambi, addiction expert and medical director
FDA recently announced the approval of Probuphine, an implantable form of buprenorphine, for treating opioid dependence. National Public Radio sought the views of Dr. Cidambi, addiction expert and medical director
Author
Product Manager
Conveniently Located Centers Across New Jersey for Accessible Care
* If the QualCare logo is on the insurance card
Questions? We'll reply soon!